The 41st Data Protection Network Meeting, hosted
by eu-LISA in Tallinn, took place on 31st May and 1st of June
in Tallinn. Twice a year the Data Protection Officers (DPO) from European Union
Institutions, Bodies and Agencies meet in order to discuss and brainstorm on
data protection related matters and reinforce collaboration efforts.
For the first time, in light of the preparations for the new
privacy rules, a member of the French Data Protection Authority (CNIL) and two
members of the DAPIX Working Party took part in the conference. Soon the
European Union data protection framework will change and be aligned with the
newly adopted General Data Protection Regulation (GDPR) and the future ePrivacy
Regulation. This modification will ensure that European Union Institutions,
Bodies and Agencies will also offer a high standard of protection while they
process personal data. In this regard eu-LISA, as operational manager of European
Union large-scale IT systems, is dedicated to comply with the data protection rules
respecting the fundamental rights of privacy and data protection of data
subjects. This point is currently of utmost importance since eu-LISA’s mandate
will soon be extended to cover news IT systems.
The European Data Protection Supervisor (EDPS) was very
satisfied of the discussions since key topics such as the role of the DPO
within organisation, Data Breach, Accountability, Privacy Impact Assessment
(PIA) and Privacy by Design and by Default were tabled and tackled during the
meeting. All the DPOs took this opportunity to exchange views, raise concerns
and learn from each other in order to gather useful knowledge for upcoming data
protection challenges. The blogpost on this topic, penned by Wojciech
Wiewiórowski, Assistant Supervisor at the EDPS, is available here.
eu-LISA’s Data Protection Office, and eu-LISA as a whole, are
very pleased with the outcome of this event. Praises on both the content and
organisation of the meeting came from all participants.
The next DPO meeting will be hosted by the European
Medicines Agency (EMA) in London.